The Bormed™ difference
Borealis experts explaining the impact of the Bormed™ Directive.
How does the Bormed™ Directive shape our development and production, and what does that mean for our healthcare partners? We’ve asked the people who know
What is the Bormed Directive?
Borealis is using the ISO standard as its quality platform however is convinced this is not enough to meet the stringent requirements of the healthcare industry. For this reason, we have our Bormed directive as additional guideline to meet the expectations of our healthcare partners.
Anja Gottschalk
Application Development Engineer
What is the scope of the Bormed Directive?
The Bormed Directive applies to the development of new Bormed resins, as well as our day-to-day operations in production. It also defines how we achieve compliance with European and US pharmacopeia, how we manage changes, and how we assess the application of Bormed materials.
Paulo Cavacas
Business Development Manager
It is fair to say that the Bormed directive has an impact on how we engage with the entire value chain. It is about how we take responsibility to support our healthcare partners and to deliver the best service to our ultimate customer: the patient.
Markus Fuchs
Sales Manager
The Bormed Directive defines the guidelines to manage the change process for our healthcare materials. Firstly, it describes that all relevant customers have to be informed long before we implement any changes to a material they are using. Secondly, from the moment we notify them of the impending change, we also offer our customers comprehensive support to ensure a smooth transition.
Emmanuel Boxus
Application Development Engineer
The Bormed Directive consists of a number of quality procedures to minimise the risk of cross contamination during product changeovers in our plants.
Faruk Unluuysal
Application Development Engineer
Many customer audits take place every year and whilst allowing our customers to see first-hand that we do what we say we do, they are an excellent opportunities to learn and therefore further develop our Bormed Directive.
Niya Petzold
Application Marketing Manager
A comprehensive partnership is key
The right time, the right place.
At Borealis and Borouge, we take an open and proactive approach to service. We work closely with our business partners and share knowledge and expertise with them to help improve their results and meet relevant healthcare standards.
We provide global support. With the Borealis head office in Vienna, the Borouge head offices in Abu Dhabi and Singapore, and local partnerships in North America among others, we have a truly global reach. Our specialists in R&D, technical support, sales, and distribution are ready to help you in 55 countries worldwide, covering 18 languages.
For more details on our global presence go to www.borealisgroup.com.
We aim to deliver the right products with the right information, when and where you need them.
In fact, our product data is always available. And you can count on us to communicate any changes to product specifications very early on.
Our joint venture company Borouge enables us to build customer relationships in India, China, South East Asia and of course the Middle East helping further expand our global reach.
Maria Ciliberti
VP Marketing and New Business Development, Polyolefins, Borealis